Law360 (May 11, 2020, 10:33 PM EDT) -- A California federal judge on Monday threw out an attorney's whistleblower False Claims Act suit alleging Valeant Pharmaceuticals fraudulently obtained a patent to block generic Apriso, ruling that the attorney "is a far cry from the quintessential whistleblower plaintiff."
Zachary Silbersher, a patent attorney who's never worked for Valeant or the other companies named in his 2018 suit, had claimed that Valeant Bausch Health subsidiary Salix Pharmaceuticals and the German company Dr. Falk Pharma GmbH violated the FCA and numerous U.S. states' false claims acts. Silbersher was involved in patent litigation invalidating the patent, which covered the anti-inflammatory drug, per his...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!